bluebird bio, Inc.

Ownership Transactions Reported by 27 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	0
Sells	4	-6.31K	100%	$2.09	-$13.2K
Net	-4	-6.31K	-100%		-$13.2K

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Jason Cole	Chief Strategy & Financial Off	$271K			Aug 19, 2022
Gina Consylman	Chief Financial Officer	$179K			Feb 1, 2022
Jessica Whitten	Chief Accounting Officer	$81.4K			Feb 1, 2022
Christopher Krawtschuk	Chief Financial Officer	$65K			Mar 1, 2024
Anne-Virginie Eggimann	Chief Regulatory Officer	$60.4K			Jul 12, 2022
Philip D. Gregory	Chief Scientific Officer	$48.8K			Nov 11, 2021
William Baird	Chief Financial Officer	$32.6K			Nov 11, 2021
Wendy L. Dixon	Director	$17K			Nov 11, 2021
Daniel Lynch	Director	$11.4K			Nov 11, 2021
William R. Sellers	Director	$5.15K			Nov 11, 2021
Denice Torres	Director	$3.9K			Nov 11, 2021
Michael Cloonan	Director	$0			Jun 2, 2025
Thomas Klima	Chief Commercial & Operating Officer	$0	-$2.86K	-100%	May 30, 2025
Charlotte Jones-Burton	Director	$0			May 30, 2025
Richard A. Colvin	Chief Medical Officer	$0	-$3.94K	-100%	May 30, 2025
Joseph Vittiglio	Chief Business & Legal Officer	$0	-$1.76K	-100%	May 30, 2025
Richard Paulson	Director	$0			May 30, 2025
O. James Sterling	Chief Financial Officer	$0			Jun 2, 2025
Nick Leschly	Director	$0			May 30, 2025
Andrew Obenshain	President and CEO, Director	$0	-$4.65K	-100%	May 30, 2025
John O. Agwunobi	Director	$0			May 30, 2025
Mark Vachon	Director	$0			May 30, 2025
Najoh Tita-Reid	Director	$0			May 30, 2025
Elisabeth Leiderman	Director	$0			May 30, 2025
Ramy Ibrahim	Director				Nov 11, 2021
Sarah Glickman	Director				Nov 11, 2021
Marcela V. Maus	Director				Nov 11, 2021

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.